Your browser doesn't support javascript.
loading
Regulatory Considerations for Clinical Trial Applications with CRISPR-Based Medicinal Products.
Anliker, Brigitte; Childs, Liam; Rau, Juliane; Renner, Matthias; Schüle, Silke; Schuessler-Lenz, Martina; Sebe, Attila.
Afiliação
  • Anliker B; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Childs L; Division Host-Pathogen Interactions, Paul Ehrlich Institute, Langen, Germany.
  • Rau J; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Renner M; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Schüle S; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Schuessler-Lenz M; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
  • Sebe A; Division of Medical Biotechnology, Paul Ehrlich Institute, Langen, Germany.
CRISPR J ; 5(3): 364-376, 2022 06.
Article em En | MEDLINE | ID: mdl-35452274
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistemas CRISPR-Cas / Edição de Genes Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article